Medical Oncology Department, Francois Baclesse Center, Caen, France.
Anticipe (Interdisciplinary Research Unit for the Prevention and Treatment of Cancer), INSERM Unit 1086, Caen, France.
Cancer. 2021 Dec 15;127(24):4636-4645. doi: 10.1002/cncr.33856. Epub 2021 Aug 16.
The COVID-19 pandemic may induce post-traumatic stress disorder (PTSD) symptoms among patients with cancer, who also face adaptations to their treatment. The authors assessed the occurrence of PTSD symptoms, investigated pandemic-induced adjustments in medical oncology practice in patients with cancer, and explored risk factors for PTSD and the association between PTSD symptoms, insomnia, and quality of life (QoL).
This prospective French study was conducted in patients with solid/hematologic tumors who were receiving medical treatment in the day care departments of 2 cancer centers during the lockdown. Adjustments to medical oncology practice were collected from medical records. PTSD (measured using the Impact of Event Scale-Revised), insomnia (measured using the Insomnia Severity Index), QoL (measured using the Functional Assessment of Cancer Therapy-General instrument), and cognitive complaints (measured using the Functional Assessment of Cancer Therapy-Cognitive Function instrument) were collected through validated questionnaires.
Clinical data and questionnaires were available for 734 and 576 patients, respectively. The median patient age was 64 years, and 69% of patients were women. Twenty-one percent of patients had PTSD. Twenty-seven percent (95% CI, 23%-30%) had an adjustment in their medical oncology program, including adjournments (29%), treatment interruptions (16%), modified treatment plans (27%), or adapted monitoring (27%). Women and patients experiencing an adjustment in oncology practice had a higher odds of PTSD (odds ratio= 2.10 [95% CI, 1.07-4.14] and 1.65 [95% CI, 1.03-2.63]; P < .05). PTSD symptoms were correlated with worse scores for QoL, cognition, and insomnia.
Twenty-one percent of patients with cancer experienced PTSD symptoms associated with poor QoL during the first COVID-19-induced lockdown. Medical oncology practice was adjusted in approximately one-quarter of patients and was associated with the occurrence of PTSD symptoms. Psychosocial support should be offered in cancer centers to promote emotional resilience and avoid PTSD symptoms in patients.
COVID-19 大流行可能会在癌症患者中引发创伤后应激障碍(PTSD)症状,他们还需要适应治疗。作者评估了 PTSD 症状的发生,调查了癌症患者在大流行期间医学肿瘤学实践的调整,并探讨了 PTSD 的风险因素以及 PTSD 症状、失眠和生活质量(QoL)之间的关联。
这是一项前瞻性法国研究,在 COVID-19 大流行期间,在 2 家癌症中心的日间病房接受治疗的实体/血液肿瘤患者中进行。从病历中收集医学肿瘤学实践的调整情况。使用修订后的事件影响量表(IES-R)评估 PTSD,使用失眠严重程度指数(ISI)评估失眠,使用癌症治疗功能评估一般量表(FACT-G)评估 QoL,使用癌症治疗认知功能量表(FACT-Cog)评估认知症状。
临床数据和问卷分别可用于 734 名和 576 名患者。患者的中位年龄为 64 岁,69%为女性。21%的患者患有 PTSD。27%(95%CI,23%-30%)的患者的医学肿瘤学计划发生了调整,包括延期(29%)、治疗中断(16%)、修改治疗计划(27%)或调整监测(27%)。女性和经历肿瘤学实践调整的患者 PTSD 的可能性更高(优势比=2.10[95%CI,1.07-4.14]和 1.65[95%CI,1.03-2.63];P<.05)。PTSD 症状与 QoL、认知和失眠评分较差相关。
在第一次 COVID-19 引发的封锁期间,21%的癌症患者出现了 PTSD 症状,生活质量较差。大约四分之一的患者的肿瘤学治疗方法进行了调整,并且与 PTSD 症状的发生有关。癌症中心应提供社会心理支持,以促进情绪适应能力并避免患者出现 PTSD 症状。